Indeed, PI3K inhibition has been suggested as therapeutic option in ES before [29] and recent evidence suggests that the pathway can modulate expression of the EWS-FLI1 fusion protein itself [30]. The gene discussed is FLI1; the disease is Ewing sarcoma.